MACSF

COMMUNIQUÉS West-GlobeNewswire

Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients
22/05/2024
May 22, 2024 Philips wearable ePatch and AI analytics platform help detect potentially life-threatening irregular heartbeats The solution helps University Hospital Vall d’Hebron achieve reduced average length of stay, [...]
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
22/05/2024
IMCIVREE expected to be funded and available for use in England and Wales within three months through the National Health Service in specialist centres BOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, [...]
deepull appoints Didier Deltort to its Board of Directors
22/05/2024
deepull appoints Didier Deltort to its Board of Directors Barcelona, Spain – 22 May 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis [...]
Arbutus to Present Imdusiran Data at EASL Congress 2024
22/05/2024
WARMINSTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to [...]
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
22/05/2024
PARIS and CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand [...]
NANOBIOTIX fait le point sur ses résultats financiers et opérationnels du premier trimestre 2024
22/05/2024
PARIS et CAMBRIDGE, Mass., 22 mai 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société » ), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
22/05/2024
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases Nantes, France - Ingelheim, Germany - 22 May 2024, 7:30am CET - [...]
OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques
22/05/2024
OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques Nantes, France et [...]
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe
22/05/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all indications of denosumab reference medicines Xgeva® and Prolia® [...]
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
22/05/2024
PRESS RELEASE: REGULATED INFORMATION – INSIDE INFORMATION 22 MAY 2024, 07:00 CEST Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump® Positive and collaborative [...]
Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk
22/05/2024
Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke. 1 The Roche Diagnostics Tina-quant® Lp(a) [...]
Predicine to Present 9 Liquid Biopsy Studies at ASCO 2024
22/05/2024
HAYWARD, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Predicine, Inc. A leading precision oncology company, announced today that it will present data from 9 ctDNA studies at ASCO 2024, spotlighting the clinical utility of [...]
Deenova enters Belgian market with tender win at AZ Saint Lucas Hospital
22/05/2024
MILAN, Italy, May 22, 2024 (GLOBE NEWSWIRE) -- Deenova , the European leader in pharmacy automation, is thrilled to announce its successful tender win at AZ Saint Lucas Hospital in Brugge, facilitated by its business [...]
Deenova entre sur le marché belge avec une victoire aux enchères à l'hôpital AZ Saint Lucas
22/05/2024
MILAN, Italie, 22 mai 2024 (GLOBE NEWSWIRE) -- Deenova , le leader européen de l'automatisation pharmaceutique, est ravi d'annoncer l’attribution de l’appel d’offres pour l’automatisation de la pharmacie de l'hôpital AZ [...]
LifeStance Health Group Announces Pricing of Secondary Public Offering
22/05/2024
SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health [...]
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
22/05/2024
WALTHAM, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with [...]
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 for the Diagnosis of Progressive Supranuclear Palsy
22/05/2024
Fast Track Designation follows announcement in January 2024 that the U.S. Food and Drug Administration (FDA) granted a “Study May Proceed” letter for APRINOIA’s planned Phase 3 study of APN-1607 (florzolotau (18F)) in [...]
Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference
22/05/2024
SOUTH SAN FRANCISCO, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the [...]
Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy
21/05/2024
La thérapie ARC Therapy™ s’est révélée sûre et efficace dans le cadre d’une étude pivot mondiale* Quatre-vingt-dix pour cent des participants ont amélioré la force ou la fonction de leurs membres supérieurs* [...]

Pages